CAMBRIDGE, Mass. & CAMBRIDGE, England–(BUSINESS WIRE)–Sep 22, 2021–
Transition Bio, Inc., (the Company) announced today that Dr. Sarah Teichmann FmedSci FRS, has joined the Company as a Scientific Co-Founder.
Dr. Teichmann is Head of Cellular Genetics and Senior Group Leader at the Wellcome Sanger Institute, with additional roles as Director of Research at the Cavendish Laboratory at the University of Cambridge, and Senior Research Fellow at Churchill College.
Dr. Teichmann joins fellow founding scientists of the Company: Professor David Weitz, the Mallinckrodt Professor of Physics and Applied Physics at Harvard University, Professor Tuomas Knowles, Professor of Physical Chemistry and Biophysics at the…